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Objective: 
To study the skeletal related complications in patients with carcinoma of prostate 
having hormonal therapy  
 
Patients & Methods: 
Patients diagnosed to have carcinoma of prostate and had either bilateral 
orchidectomy or commencements of LHRH analogue injection from 1st January, 
2007 to 31st December, 2009 in Queen Mary Hospital were studied. Basic 
characteristics, presence of skeletal related complications and related information 
were collected. Data were processed with SPSS. 
 
Results: 
A total of 106 patients were studied. 46 patients had bilateral orchidectomy done and 
60 patients had LHRH analogue injection started. The skeletal related complication 
rate was low. Patients with metastatic carcinoma of prostate had higher chance of 
skeletal related complication rate compared with those with non-metastatic disease. 
 
Conclusions: 
Skeletal related complications cause significant impact to patients with carcinoma of 
prostate. Metastatic carcinoma of prostate increases the risk of pathological fracture. 
Hormonal therapy for patients with carcinoma of prostate decreases the chance of 
pathological fracture but leads to osteoporosis. Patients with metastatic carcinoma of 
prostate had higher chance of skeletal related complication rate compared with those 
with non-metastatic disease. 
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